| 000 | 01676 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516201132.0 | ||
| 264 | 0 | _c20150604 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1816-5370 | ||
| 024 | 7 |
_a10.1177/0218492314521421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVu, Thang Duc | |
| 245 | 0 | 0 |
_aIs continuation of antiplatelets until coronary artery bypass safe in Asians? _h[electronic resource] |
| 260 |
_bAsian cardiovascular & thoracic annals _cOct 2014 |
||
| 300 |
_a909-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 |
_aBlood Loss, Surgical _xprevention & control |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 |
_aCoronary Artery Bypass _xadverse effects |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPostoperative Hemorrhage _xchemically induced |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSingapore |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZaw, Min Htet | |
| 700 | 1 | _aChang, Guohao | |
| 700 | 1 | _aHu, Shu Lin Jesse | |
| 700 | 1 | _aTay, Chee Wei Bobby | |
| 700 | 1 | _aNg, Celene Wei Qi | |
| 700 | 1 | _aChia, Daryl K A | |
| 700 | 1 | _aLee, Chuen Neng | |
| 700 | 1 | _aKofidis, Theo | |
| 773 | 0 |
_tAsian cardiovascular & thoracic annals _gvol. 22 _gno. 8 _gp. 909-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0218492314521421 _zAvailable from publisher's website |
| 999 |
_c23600294 _d23600294 |
||